Decoy NF-κB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells

David G Lott, Olivia Dan, Lina Lu, Marshall Strome

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objectives/Hypothesis: The increased risk of malignancy associated with post-transplant immunosuppression limits the potential of laryngeal transplantation as a reconstructive option. This risk may be mitigated by utilizing decoy nuclear factor kappa B (NF-κB) immature dendritic cells (iDC) to provide donor-specific tolerance. The purpose of this study was to explore whether tolerogenic properties of iDC can be applied to composite tissue transplantation. Study Design: Animal study. Methods: Five iDC-injected mice were euthanized at 15, 30, and 60 days post-laryngeal transplant. Control groups included five transplanted mice without immunosuppression, one iDC-injected mouse euthanized prior to transplantation, one mouse without injection or transplantation, and one mouse administered mature DC to serve as an accelerated rejection control. Larynges were graded for rejection severity according to a grading scale. Draining lymph nodes and spleens were evaluated by flow cytometry to determine immunogenic activity of iDC and T cells locally and peripherally. Results: Each time group demonstrated moderate allograft rejection (rejection severity scores: 4.38, 5.10, 5.29). NF-κB iDC-treated mice had significantly less rejection at all time points compared to nonimmunosuppressed mice. Flow cytometry showed inhibition of cytotoxic T cell infiltration and expansion of regulatory T cells at the allograft site. Conclusions: iDC immunosuppression maintains laryngeal allograft integrity up to 60 days posttransplantation. Regulatory T cells are enhanced at the allograft site, which serves to suppress immune cell activation and induce self-antigen tolerance. iDC injection may lessen post-transplant comorbidities by decreasing the systemic immune response and favorably affecting concurrent immunosuppressive dose sequencing for laryngeal allograft preservation.

Original languageEnglish (US)
Pages (from-to)44-52
Number of pages9
JournalLaryngoscope
Volume120
Issue number1
DOIs
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

NF-kappa B
Regulatory T-Lymphocytes
Dendritic Cells
Allografts
Immunosuppression
Transplantation
Transplants
Flow Cytometry
T-Lymphocytes
Tissue Transplantation
Injections
Autoantigens
Immunosuppressive Agents
Larynx
Comorbidity
Spleen
Lymph Nodes
Control Groups

Keywords

  • Dendritic cells
  • Immunosuppression
  • Laryngeal transplantation
  • Larynx
  • Larynx transplant
  • Nuclear factor kappa B (NF-κB)

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Medicine(all)

Cite this

Decoy NF-κB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells. / Lott, David G; Dan, Olivia; Lu, Lina; Strome, Marshall.

In: Laryngoscope, Vol. 120, No. 1, 01.2010, p. 44-52.

Research output: Contribution to journalArticle

@article{15dd7000885e4f7e861fcd35729da8e9,
title = "Decoy NF-κB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells",
abstract = "Objectives/Hypothesis: The increased risk of malignancy associated with post-transplant immunosuppression limits the potential of laryngeal transplantation as a reconstructive option. This risk may be mitigated by utilizing decoy nuclear factor kappa B (NF-κB) immature dendritic cells (iDC) to provide donor-specific tolerance. The purpose of this study was to explore whether tolerogenic properties of iDC can be applied to composite tissue transplantation. Study Design: Animal study. Methods: Five iDC-injected mice were euthanized at 15, 30, and 60 days post-laryngeal transplant. Control groups included five transplanted mice without immunosuppression, one iDC-injected mouse euthanized prior to transplantation, one mouse without injection or transplantation, and one mouse administered mature DC to serve as an accelerated rejection control. Larynges were graded for rejection severity according to a grading scale. Draining lymph nodes and spleens were evaluated by flow cytometry to determine immunogenic activity of iDC and T cells locally and peripherally. Results: Each time group demonstrated moderate allograft rejection (rejection severity scores: 4.38, 5.10, 5.29). NF-κB iDC-treated mice had significantly less rejection at all time points compared to nonimmunosuppressed mice. Flow cytometry showed inhibition of cytotoxic T cell infiltration and expansion of regulatory T cells at the allograft site. Conclusions: iDC immunosuppression maintains laryngeal allograft integrity up to 60 days posttransplantation. Regulatory T cells are enhanced at the allograft site, which serves to suppress immune cell activation and induce self-antigen tolerance. iDC injection may lessen post-transplant comorbidities by decreasing the systemic immune response and favorably affecting concurrent immunosuppressive dose sequencing for laryngeal allograft preservation.",
keywords = "Dendritic cells, Immunosuppression, Laryngeal transplantation, Larynx, Larynx transplant, Nuclear factor kappa B (NF-κB)",
author = "Lott, {David G} and Olivia Dan and Lina Lu and Marshall Strome",
year = "2010",
month = "1",
doi = "10.1002/lary.20667",
language = "English (US)",
volume = "120",
pages = "44--52",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Decoy NF-κB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells

AU - Lott, David G

AU - Dan, Olivia

AU - Lu, Lina

AU - Strome, Marshall

PY - 2010/1

Y1 - 2010/1

N2 - Objectives/Hypothesis: The increased risk of malignancy associated with post-transplant immunosuppression limits the potential of laryngeal transplantation as a reconstructive option. This risk may be mitigated by utilizing decoy nuclear factor kappa B (NF-κB) immature dendritic cells (iDC) to provide donor-specific tolerance. The purpose of this study was to explore whether tolerogenic properties of iDC can be applied to composite tissue transplantation. Study Design: Animal study. Methods: Five iDC-injected mice were euthanized at 15, 30, and 60 days post-laryngeal transplant. Control groups included five transplanted mice without immunosuppression, one iDC-injected mouse euthanized prior to transplantation, one mouse without injection or transplantation, and one mouse administered mature DC to serve as an accelerated rejection control. Larynges were graded for rejection severity according to a grading scale. Draining lymph nodes and spleens were evaluated by flow cytometry to determine immunogenic activity of iDC and T cells locally and peripherally. Results: Each time group demonstrated moderate allograft rejection (rejection severity scores: 4.38, 5.10, 5.29). NF-κB iDC-treated mice had significantly less rejection at all time points compared to nonimmunosuppressed mice. Flow cytometry showed inhibition of cytotoxic T cell infiltration and expansion of regulatory T cells at the allograft site. Conclusions: iDC immunosuppression maintains laryngeal allograft integrity up to 60 days posttransplantation. Regulatory T cells are enhanced at the allograft site, which serves to suppress immune cell activation and induce self-antigen tolerance. iDC injection may lessen post-transplant comorbidities by decreasing the systemic immune response and favorably affecting concurrent immunosuppressive dose sequencing for laryngeal allograft preservation.

AB - Objectives/Hypothesis: The increased risk of malignancy associated with post-transplant immunosuppression limits the potential of laryngeal transplantation as a reconstructive option. This risk may be mitigated by utilizing decoy nuclear factor kappa B (NF-κB) immature dendritic cells (iDC) to provide donor-specific tolerance. The purpose of this study was to explore whether tolerogenic properties of iDC can be applied to composite tissue transplantation. Study Design: Animal study. Methods: Five iDC-injected mice were euthanized at 15, 30, and 60 days post-laryngeal transplant. Control groups included five transplanted mice without immunosuppression, one iDC-injected mouse euthanized prior to transplantation, one mouse without injection or transplantation, and one mouse administered mature DC to serve as an accelerated rejection control. Larynges were graded for rejection severity according to a grading scale. Draining lymph nodes and spleens were evaluated by flow cytometry to determine immunogenic activity of iDC and T cells locally and peripherally. Results: Each time group demonstrated moderate allograft rejection (rejection severity scores: 4.38, 5.10, 5.29). NF-κB iDC-treated mice had significantly less rejection at all time points compared to nonimmunosuppressed mice. Flow cytometry showed inhibition of cytotoxic T cell infiltration and expansion of regulatory T cells at the allograft site. Conclusions: iDC immunosuppression maintains laryngeal allograft integrity up to 60 days posttransplantation. Regulatory T cells are enhanced at the allograft site, which serves to suppress immune cell activation and induce self-antigen tolerance. iDC injection may lessen post-transplant comorbidities by decreasing the systemic immune response and favorably affecting concurrent immunosuppressive dose sequencing for laryngeal allograft preservation.

KW - Dendritic cells

KW - Immunosuppression

KW - Laryngeal transplantation

KW - Larynx

KW - Larynx transplant

KW - Nuclear factor kappa B (NF-κB)

UR - http://www.scopus.com/inward/record.url?scp=74049129985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74049129985&partnerID=8YFLogxK

U2 - 10.1002/lary.20667

DO - 10.1002/lary.20667

M3 - Article

C2 - 19877191

AN - SCOPUS:74049129985

VL - 120

SP - 44

EP - 52

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 1

ER -